Ferring launches nocturia drug for adults of all ages
Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages.
Read More
Tag: nocturia
FDA panel backs Allergan’s night-time urination nasal spray
US regulatory advisors are backing clearance of Allergan’s SER120, a low-dose nasal formulation of desmopressin designed to treat night-time urination.
Read More
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
